CALUMET SPECIALTY PRODUCTS (CLMT)
US1314761032
ChartMill assigns a Buy % Consensus number of 80% to CLMT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 23.77. This target is 49.75% above the current price.
CLMT was analyzed by 13 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CLMT.
In the previous month the buy percentage consensus was at a similar level.
CLMT was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-12-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-10-31 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-13 | Goldman Sachs | Maintains | Buy |
| 2023-05-15 | UBS | Maintains | Neutral -> Neutral |
| 2023-05-08 | TD Cowen | Maintains | Outperform |
| 2023-05-08 | Wells Fargo | Maintains | Overweight |
| 2023-01-25 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-14 | UBS | Initiate | Neutral |
| 2022-08-18 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2022-06-28 | Cowen & Co. | Maintains | Outperform |
| 2022-05-09 | Cowen & Co. | Maintains | Outperform |
| 2022-04-21 | Wells Fargo | Maintains | Overweight |
| 2022-02-28 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-23 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2021-11-23 | Cowen & Co. | Upgrade | Market Perform -> Outperform |
| 2021-10-15 | Goldman Sachs | Maintains | Neutral |
| 2021-10-08 | Wells Fargo | Maintains | Overweight |
| 2021-10-04 | HC Wainwright & Co. | Initiate | Buy |
| 2021-03-24 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |